Stockscreener 앱 받기
2.62
4.73%
-0.13
시장 영업 전:
2.65
0.03
+1.15%
전일 마감가:
$2.75
열려 있는:
$2.75
하루 거래량:
1.55M
Relative Volume:
0.29
시가총액:
$126.05M
수익:
-
순이익/손실:
$-97.22M
주가수익비율:
-1.8986
EPS:
-1.38
순현금흐름:
$-82.44M
1주 성능:
+0.38%
1개월 성능:
+11.49%
6개월 성능:
-74.01%
1년 성능:
-90.07%
1일 변동 폭
$2.61
$2.77
1주일 범위
$2.61
$2.83
52주 변동 폭
$2.23
$42.20
카사바 Stock (SAVA) Company Profile
명칭
Cassava Sciences Inc
전화
512-501-2444
주소
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
SAVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.62 | 126.05M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
카사바 Stock (SAVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-27 | 개시 | B. Riley Securities | Buy |
| 2021-02-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-01-10 | 재확인 | Maxim Group | Buy |
모두보기
카사바 주식(SAVA)의 최신 뉴스
CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. – SAVA - GlobeNewswire Inc.
SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - PR Newswire
Cassava Sciences, Inc. Investors: February 10, 2025 Filing Deadline in Securities Class Action - GlobeNewswire Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire
CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: - GlobeNewswire
2025-01-20 | Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:SAVA | Press Release - Stockhouse Publishing
Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
2025-01-19 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing
CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - PR Newswire
2025-01-17 | Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing
CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Shareholders of Cassava Sciences, Inc. Should Contact Levi - GlobeNewswire
SAVA Announcement: Contact Kessler Topaz Meltzer & Check, - GlobeNewswire
Shareholders of Cassava Sciences, Inc. Should Contact The - GlobeNewswire
Simufilam’s Collapse Leaves Cassava Searching For A Viable Future (NASDAQ:SAVA) - Seeking Alpha
CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - AccessWire
Shareholders that Lost Money on Cassava Sciences, Inc. (SAVA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - AccessWire
Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights – SAVA - AccessWire
SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces - WICZ
CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cassava Sciences, Inc. Investors of Upcoming Deadline - WICZ
Cassava Sciences, Inc. Sued for Securities Law Violations – - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - Stockhouse Publishing
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - AccessWire
SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Cassava - GlobeNewswire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure - The Bakersfield Californian
Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - AccessWire
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Lost Money on Cassava Sciences, Inc. (SAVA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - AccessWire
Shareholders that lost money on Cassava Sciences, Inc. (SAVA) should contact Levi & Korsinsky about pending Class ActionSAVA - AccessWire
Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the - GuruFocus.com
Cassava Sciences, Inc. (SAVA) Investors: February 10, 2025 Filing Deadline in Securities Class Action - GlobeNewswire Inc.
Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - Finansavisen
SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Shareholders that lost money on Cassava Sciences, Inc.(SAVA) should contact Levi & Korsinsky about pending Class ActionSAVA - AccessWire
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
2025-01-08 | Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:SAVA | Press Release - Stockhouse Publishing
Cassava Sciences issues layoffs, regroups after failed drug study - The Business Journals
Cassava Sciences, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights – SAVA - AccessWire
Cassava Sciences Announces Reduction in Workforce -January 07, 2025 at 04:30 pm EST - Marketscreener.com
Cassava Sciences, Inc. Investors: Please contact the - GlobeNewswire
Cassava laying off one-third of staff to curb expenses (SAVA:NASDAQ) - Seeking Alpha
Cassava Sciences to reduce workforce by 33% - TipRanks
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Cassava Sciences Provides a Business Update - The Manila Times
Cassava Sciences Cuts 33% of Workforce After Failed Alzheimer's Trial, Plans Study Closures - StockTitan
카사바 (SAVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
카사바 주식 (SAVA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Option Exercise |
1.18 |
50,000 |
59,000 |
71,300 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.86 |
59,800 |
230,828 |
11,500 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.82 |
2,000 |
7,640 |
0 |
4.81%
자본화:
|
볼륨(24시간):